Your session is about to expire
← Back to Search
Brain Stimulation
A Pilot Study of the Immediate Effects of DLPFC tDCS on Attention Bias in Depression
N/A
Waitlist Available
Led By Leigh Charvet, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up study tdcs administration visit (day1), pre-tdcs administration time (1 hour)
Awards & highlights
No Placebo-Only Group
Summary
This trial will test if a session of non-invasive brain stimulation can change how women aged 18-45 with mild to moderate depression focus on negative information. This technique has shown promise in treating major depressive disorder.
Eligible Conditions
- Depression
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ study tdcs administration visit (day1), pre-tdcs administration time (1 hour)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~study tdcs administration visit (day1), pre-tdcs administration time (1 hour)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Analog Mood Scale (AMS) Anxiety Score
Analog Mood Scale (AMS) Happy Score
Analog Mood Scale (AMS) Sad Score
+4 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Female participants with DepressionExperimental Treatment1 Intervention
Female participants with mild to moderate depression to determine if a single-session of tDCS can alter negative attention bias. The primary objective is to study if single-session tDCS will affect attention bias in depression and is not meant to treat depression.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcranial direct current stimulation (tDCS)
2016
Completed Phase 3
~890
Find a Location
Who is running the clinical trial?
NYU Langone HealthLead Sponsor
1,415 Previous Clinical Trials
856,182 Total Patients Enrolled
22 Trials studying Depression
1,581 Patients Enrolled for Depression
Leigh Charvet, MDPrincipal InvestigatorNYU Langone Health
7 Previous Clinical Trials
378 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a history of seizures that are not well controlled.You are currently struggling with drug or alcohol addiction.You are pregnant or breastfeeding.You have had a head injury within the past year.You are a female.You have implants in your head or neck.Depression that is not severe, as judged by how low the person's BDI-II score is.If you are taking antidepressants, your medication must be stable for 30 days prior to screening.You have a neurological condition that makes it impossible for you to participate in the study, as determined by the study clinician.You have a skin condition or sensitive skin in areas where the study treatment will be applied or administered.
Research Study Groups:
This trial has the following groups:- Group 1: Female participants with Depression
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Depression Patient Testimony for trial: Trial Name: NCT05188248 — N/A